Inactivation by methylation of a gene encoding for a receptor for retinoic acid may be an early step in the development of breast cancer. Evidence suggests that demethylating agents can reverse this inactivation. Once the receptor protein is expressed, retinoic acid can be used to manipulate the uncontrolled proliferation of the cancer cells.
Go to Previous Page
Go to Next Page